Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Deracoxib is a non-steroidal anti-inflammatory drug (NSAID) and selective inhibitor of COX-2 (IC50s = 0.63 and 23 μM for COX-2 and COX-1, respectively).1 In vivo, deracoxib (0.3-10 mg/kg) increases weight bearing and decreases lameness and joint effusion in a canine model of urate crystal-induced intraarticular synovitis.2 Deracoxib induces less lesion formation in the gastric mucosa of healthy canines than aspirin (Item No. 70260) when administered at a dose of 1.5 mg/kg.3 Formulations containing deracoxib have been used in the treatment of pain associated with canine osteoarthritis.
WARNING This product is not for human or veterinary use.
1. Discovery of a potent, selective and orally active canine COX-
2. Effect of deracoxib, a new COX-
3. Effects of deracoxib or buffered aspirin on the gastric mucosa of healthy dogs. J. Vet. Intern. Med. 20(6), 1291-1296 (2006).